Update (9:40 a.m.): Updated with Wednesday market open information.
The stock was flat at 9:38 a.m. on Wednesday.
Vale may be worth following again. Bristol-Myers? Not so much.
Cramer says P&G is a good choice and is disappointed by Bristol-Myers Squibb.
A malaise has once again befallen America, Cramer says.